In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

IntraLase nets $86.8mm with IPO

Executive Summary

IntraLase (designs, develops, and sells LASIK surgical vision products) has completed its IPO, netting $86.8mm through the sale of 7.3mm common shares (including the overallotment) priced at $13 each (the high end of its estimated price range). The shares will trade on the Nasdaq under the symbol ILSE. Selling shareholders also offered 336k shares.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register